The Business
Research Company published its Gastrointestinal Drugs Global Market Report 2020
which provides strategists, marketers and senior management with the critical
information they need to assess the global Gastrointestinal Drugs market. The
report provides in-depth analysis of the impact of COVID-19 on the market,
along with revised market numbers due to the effects of the coronavirus.
The report covers the gastrointestinal
drugs market’s segments-
1) By Type:
Antacids, Antiulcerants, Vitamin And Minerals, Antiobesity, Antiemetics And
Antinauseants, Antidiarrhoeals
2) By
Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores,
Others
3) By Route
Of Administration: Oral, Parenteral, Others
4) By Drug
Classification: Branded Drugs, Generic Drugs
5) By Mode
Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
View Complete Report:
Gastrointestinal Drugs Global Market Report 2020 is the most
comprehensive report available on this market and will help gain a truly global
perspective as it covers 60 geographies. The chapter on the impact of COVID-19
gives valuable insights on supply chain disruptions, logistical challenges, and
other economic implications of the virus on the market. The chapter also covers
markets which have been positively affected by the pandemic.
The global gastrointestinal drugs market is expected to grow
from $42.8 billion in 2019 to $48.5 billion in 2020 at a compound annual growth
rate (CAGR) of 13.4%. The growth is mainly due to the impact of COVID-19 on the
digestive system. The digestive system manifestations in patients with COVID-19
include poor appetite, nausea, vomiting, diarrhea, abnormal liver enzymes,
abdominal pain, and gastrointestinal bleeding. Patients with pre-existing
digestive diseases such as inflammatory bowel disease may complain about
exacerbation of symptoms or disease activity. The market is then expected to
stabilize and grow at a CAGR of 4% from 2021 and reach $55.4 billion in 2023.
Drug manufacturing companies are offering tranexamic acid
for the treatment of acute gastrointestinal bleeding. Tranexamic acid is a
medication used to treat or prevent excessive blood loss from major trauma or
surgery and is now finding applications for gastrointestinal diseases.
Few Points From Table Of Content
1. Executive
Summary
2. Report Structure
3. Gastrointestinal Drugs Market Characteristics
4. Gastrointestinal Drugs Market Product Analysis
5. Gastrointestinal Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
2. Report Structure
3. Gastrointestinal Drugs Market Characteristics
4. Gastrointestinal Drugs Market Product Analysis
5. Gastrointestinal Drugs Market Supply Chain
……
20. Key Mergers And Acquisitions In The Gastrointestinal Drugs Market
21. Market Background: Pharmaceutical Drugs Market
22. Recommendations
23. Appendix
24. Copyright And Disclaimer
Request A Sample Report At: https://www.thebusinessresearchcompany.com/sample.aspx?id=2136&type=smp
Few Points From List
Of Tables
Table 1: Historic Market Growth, Value ($ Billion)
Table 2: Forecast Market Growth, Value ($ Billion)
Table 3: Global Gastrointestinal Drugs Market, 2019, By
Region, Value ($ Billion)
Table 4: Global Gastrointestinal Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Historic And Forecast, By Region
………
Table 115: Global Pharmaceutical Drugs Market, 2015-2019,
2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)
Table 116: Global Gastrointestinal Drugs Market In 2023-
Growth Countries
Table 117: Global Gastrointestinal Drugs Market In 2023-
Growth Segments
Table 118: Global Gastrointestinal Drugs Market In 2023-
Growth Strategies
About The Business
Research Company:
The Business
Research Company is a Business Intelligence Company which excels in company,
market and consumer research. It has offices in the UK, the US and India and a
network of trained researchers in 52 countries globally.
Contact Information:
The Business Research
Company
Europe: +44 207 1930
708
Asia: +91 8897263534
Americas: +1 315 623
0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
